1,177
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route

, &
Pages 311-318 | Received 16 May 2013, Accepted 13 Aug 2013, Published online: 30 Sep 2013

Figures & data

Table 1. Composition and properties of different RS REVs.

Figure 1. Scanning electron microscopy pictures of formula L7 at (a) 5000× and (b) 50 000×.

Figure 1. Scanning electron microscopy pictures of formula L7 at (a) 5000× and (b) 50 000×.

Figure 2. Cumulative amount of RS released from REVs prepared using (a) l-α-phosphatidylcholine, (b) DPPC.

Figure 2. Cumulative amount of RS released from REVs prepared using (a) l-α-phosphatidylcholine, (b) DPPC.

Figure 3. Histological examination of rat lung tissue after 24 h of intra-tracheal administration of (a) PBS as negative control in group I, (b) Formula L7 in group II.

Figure 3. Histological examination of rat lung tissue after 24 h of intra-tracheal administration of (a) PBS as negative control in group I, (b) Formula L7 in group II.
Supplemental material

Supplementary Material

Download PDF (7.9 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.